Blog Archives

Roche’s Rituxan Cures Rare Skin-Blistering Disease in Study

Roche Holding AG (ROG)’s top-selling drug Rituxan effectively cured most cases of a rare and deadly skin disease in a patient study that suggests the medicine may replace steroids as the standard treatment. In a trial among 22 people with

Tagged with: , , , , , , , ,
Posted in Around the Globe, News and Information, Treatment and Medication

A Case of Pyodermatitis-Pyostomatitis Vegetans.

Pyodermatitis-pyostomatitis vegetans (PD-PSV) is a rare disorder characterized by mucocutaneous involvement and associated with inflammatory bowel disease. A 42-year-old woman with ulcerative colitis who manifested verrucous and pyogenic lesions on her scalp, neck, axillae, inguinal areas, umbilicus, trunk and oral

Tagged with: , ,
Posted in Around the Globe, News and Information

Ultrastructure of acantholysis in pemphigus foliaceus re-examined from the current perspective

Background  Pemphigus foliaceus (PF) is a chronic cutaneous autoimmune blistering disease that is characterized by superficial blistering of the skin, and according to the current perspective is caused by autoantibodies directed against desmoglein (Dsg) 1. Objectives  To examine early acantholysis

Tagged with: , , , ,
Posted in Around the Globe, News and Information

Study of oral, ear, nose and throat involvement in pemphigus vulgaris by endoscopic examination.

Background:  Pemphigus vulgaris (PV) is an autoimmune blistering skin disorder characterized by the presence of suprabasal acantholysis and autoantibodies against desmoglein 3. There are two different clinical forms: mucocutaneous (MCPV) or mucosal (MPV). However, it is not clear how PV

Tagged with: , , ,
Posted in Around the Globe, News and Information
JOIN TODAY!
The P/P Registry has been approved by the Western Institutional Review Board (WIRB) and is actively enrolling participants.

ENGLISH VERSION

SPANISH VERSION